Gambia vs Saint Vincent and the Grenadines: Previously treated cases tested for RR-/MDR-TB
Gambia
100.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2022
Gambia rank
1st
Saint Vincent and the Grenadines rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Gambia
- Saint Vincent and the Grenadines
How they compare
Gambia currently reports 100.0% against 100.0% in Saint Vincent and the Grenadines, a difference of 0.0%.
The two have swapped places 2 times across 5 shared years of data; in 2012 it was Saint Vincent and the Grenadines ahead.
Gambia ranks 1st and Saint Vincent and the Grenadines ranks 1st of 180 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 48.3% | 33.3% | 15.0% | Gambia |
| 2020s | 100.0% | 50.0% | 50.0% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Gambia or Saint Vincent and the Grenadines?
- Gambia, at 100.0% against 100.0% in Saint Vincent and the Grenadines as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Gambia and Saint Vincent and the Grenadines?
- 0.0%, with Gambia ahead.
- How many years of comparable data are there for Gambia and Saint Vincent and the Grenadines?
- 5 years are reported by both, from 2012 to 2022.
- How do Gambia and Saint Vincent and the Grenadines rank globally for previously treated cases tested for rr-/mdr-tb?
- Gambia ranks 1st and Saint Vincent and the Grenadines ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.